NUS Yong Loo Lin School of Medicine

NUS Yong Loo Lin School of Medicine Official account of the NUS Yong Loo Lin School of Medicine

House rule: Should you leave a note, do be kind, respectful and responsible.

NUS Medicine reserves the right to remove inappropriate material, to ensure a safe space for all our visitors. The NUS Yong Loo Lin School of Medicine is Singapore’s first and largest medical school. Our enduring mission centres on nurturing highly competent, values-driven and inspired healthcare professionals to transform the practice of medicine and improve health around the world. Through a dyn

amic and future-oriented five-year curriculum that is inter-disciplinary and inter-professional in nature, our students undergo a holistic learning experience that exposes them to multiple facets of healthcare and prepares them to become visionary leaders and compassionate doctors and nurses of tomorrow. Since the School’s founding in 1905, more than 12,000 graduates have passed through our doors. In our pursuit of health for all, our strategic research programmes focus on innovative, cutting-edge biomedical research with collaborators around the world to deliver high impact solutions to benefit human lives. The School is the oldest institution of higher learning in the National University of Singapore and a founding institutional member of the National University Health System. It is one of the leading medical schools in Asia and ranks among the best in the world (Times Higher Education World University Rankings 2024 by subject and the Quacquarelli Symonds (QS) World University Rankings by subject 2023). For more information about NUS Medicine, please visit http://nusmedicine.nus.edu.sg .

📢 We are pleased to announce the launch of the Neuroscience Translational Research Programme (TRP) at NUS Medicine, and ...
08/06/2026

📢 We are pleased to announce the launch of the Neuroscience Translational Research Programme (TRP) at NUS Medicine, and the appointment of Prof Rickie Patani as the inaugural Programme Chair.

👨🏽‍🔬 A distinguished physician-scientist with over two decades of experience in neurodegenerative research, Prof Patani has made significant contributions to the field, particularly through his work using human iPSC models to advance understanding of neurological diseases. His achievements have been recognised with numerous accolades, including the Lister Research Prize and the Goulstonian Lectureship, and most recently, his election as a Fellow of the Academy of Medical Sciences in 2025.

Join us in congratulating Prof Patani as he spearheads efforts to transform neuroscience research and drive new breakthroughs in neurological care. 👏🏼

📖 Find out more with the link in comments below 👇

🤝✨ Driving the next frontier of musculoskeletal health through AI and collaboration.NUS Medicine and The Hong Kong Polyt...
08/06/2026

🤝✨ Driving the next frontier of musculoskeletal health through AI and collaboration.

NUS Medicine and The Hong Kong Polytechnic University (PolyU) have formalised a new Memorandum of Understanding (MOU) to jointly advance AI-enabled community musculoskeletal research, marking a significant step forward in tackling one of the most prevalent health challenges.

This partnership aims to accelerate interdisciplinary research and innovation in musculoskeletal health. Together, both institutions will explore how AI-driven insights, digital health technologies, and data science can be harnessed to improve early detection, prevention, and management of musculoskeletal conditions in an ageing population. 🧓👵

Find out more with the link in comments below 👇

🌏✈️ The NUS Medical Society's International Relations arm organised a student cultural visit to Keio University in Japan...
04/06/2026

🌏✈️ The NUS Medical Society's International Relations arm organised a student cultural visit to Keio University in Japan that took place from 7 to 9 May.

Following Keio University's visit to NUS Medicine in 2025, the exchange offered students a chance to experience a different medical education environment, engage with peers overseas, and explore cultural perspectives that shape healthcare and medical training.

🤝 The trip also provided opportunities for cultural exchange, friendship and reflection, deepening students' appreciation of diverse perspectives in healthcare and strengthening international connections that will shape the future of medicine.

📊 A GUSTO study suggests boys and girls may develop depressive symptoms differently 🧠Conducted by researchers from A*STA...
04/06/2026

📊 A GUSTO study suggests boys and girls may develop depressive symptoms differently 🧠

Conducted by researchers from A*STAR Institute for Human Development and Potential, KK Women’s and Children’s Hospital, National University Health System, , and McGill University, they've found that patterns of brain development in early childhood may be linked to depressive symptoms in adolescence, with notable differences between boys and girls.

Published in Molecular Psychiatry, the study drew on data from the Growing Up in Singapore Towards healthy Outcomes (GUSTO) birth cohort and analysed brain scans collected at ages 4.5, 6 and 7.5. The findings highlight the importance of considering sex-specific trajectories in future mental health research and interventions.

🔗 Read more: https://medicine.nus.edu.sg/news/new-gusto-study-suggests-boys-and-girls-may-develop-depressive-symptoms-differently/

🧐What role should governments play in shaping public health choices?💬🔎Dr Johannes Kniess from Newcastle University explo...
03/06/2026

🧐What role should governments play in shaping public health choices?💬

🔎Dr Johannes Kniess from Newcastle University explores the ethical tensions between personal freedom and state responsibility, drawing on examples such as New Zealand’s to***co restrictions and Singapore’s va**ng bans.

His research examines how governments navigate the balance between respecting individual autonomy and protecting populations from health harms.🙋⚖️🧘‍♂️

👇Catch the podcast link in the comments below!

CBmE&U is a podcast developed by the Centre for Biomedical Ethics at to promote awareness and debate in bioethics. The podcast showcases researchers interviewing international guests on various topics in biomedical research and healthcare.

**ng

This World No To***co Day, let’s look at the science of addiction. NUS Medicine researchers have been using a Juvenile Z...
31/05/2026

This World No To***co Day, let’s look at the science of addiction.

NUS Medicine researchers have been using a Juvenile Zebrafish Model to uncover how our genetic makeup influences how our brains react to ni****ne. Especially, when the exposure to ni****ne happens an early age when our brains are still developing.

Swipe to learn why “smoke-free” doesn’t mean “risk-free” and how certain genes might make quitting even harder.

***coDay

🎙️ Is feminist science more than just having more women in STEM? Could science itself be feminist?In this thought-provok...
29/05/2026

🎙️ Is feminist science more than just having more women in STEM? Could science itself be feminist?

In this thought-provoking episode, Prof Deboleena Roy, a neuroscientist and behavioural biologist from Emory University joins our hosts Dr James Edgar Lim and Dr Sinead Prince to unpack what it truly means to do feminist science and be a feminist scientist. 👩‍🔬

From questioning scientific language and metaphors to challenging competitive norms, she highlights how new perspectives can uncover richer, more inclusive ways of understanding the world. 🌏

CBmE&U is a podcast developed by the Centre for Biomedical Ethics at NUS Medicine to promote awareness and debate in bioethics. The podcast showcases researchers interviewing international guests on various topics in biomedical research and healthcare.



👇Tune in to link in comments below:

🌱 Can what you eat make menopause easier to manage?📚 A long-term JAMA Network Open study, co-led by Prof Zhang Cuilin. D...
28/05/2026

🌱 Can what you eat make menopause easier to manage?

📚 A long-term JAMA Network Open study, co-led by Prof Zhang Cuilin. Director of the Global Centre for Asian Women’s Health (GloW) at NUS Medicine and Prof Frank B. Hu from Harvard T.H. Chan School of Public Health, suggests eating more plant-based, low-insulinemic foods may help manage menopause-related weight gain.

🙍‍♀️ Tracking nearly 40,000 women over decades, researchers found that diets rich in whole grains, vegetables, fruits, nuts, and legumes were linked to less weight gain and lower obesity risk during menopause. In contrast, diets high in processed foods, red meat, and sodium were associated with greater weight gain.

👉 Read more: https://medicine.nus.edu.sg/news/plant-forward-and-low-insulinemic-diets-may-help-reduce-weight-gain-and-obesity-risk-during-menopause-long-term-study-finds/

The new study was co-led by Prof Zhang Cuilin, Director of GloW at NUS Medicine, and Prof Frank B. Hu, Chair at the Department of Nutrition, Harvard T.H. Chan School of Public Health.

World Blood Cancer Day🩸is a reminder of why our work matters.At NUS Medicine, we’re proud to highlight three leading res...
28/05/2026

World Blood Cancer Day🩸is a reminder of why our work matters.

At NUS Medicine, we’re proud to highlight three leading researchers driving clinical innovation in blood cancers: Prof Chng Wee Joo, Asst Prof Anand Jeyasekharan, and Prof Allen Yeoh — all members of the NUS Centre for Cancer Research, NUS Medicine (N2CR), the School’s Cancer Translational Research Programme. Their work is advancing our understanding of blood cancers to improve treatments for our patients.

Together, these efforts reflect our commitment to the next generation of clinical innovation, where research translates into better care and outcomes for patients.

🎉 Congratulations to Prof Sylvie Alonso on her promotion to Full Professor at NUS Medicine 👏Prof Alonso, Co-Chair of the...
26/05/2026

🎉 Congratulations to Prof Sylvie Alonso on her promotion to Full Professor at NUS Medicine 👏

Prof Alonso, Co-Chair of the Infectious Diseases Translational Research Programme and from the Department of Microbiology and Immunology at , is a recognised expert in infectious diseases and RNA virology. She is known for her pioneering work on host pathogen interactions and vaccine development, particularly in dengue, Hand, Foot and Mouth Disease (HFMD), and other viral diseases of major relevance to Asia.

Her research has advanced understanding of viral fitness, virulence, and immune responses through the development of clinically relevant preclinical models and vaccine platforms. Prof Alonso is also the Deputy Director of the Life Sciences Institute and Lead of the Vaccines & Therapeutics Co-operative under Singapore’s PREPARE Programme, where she contributes to shaping research strategy and strengthening multidisciplinary collaboration.

Address

NUS Medicine Dean's Office, 1E Kent Ridge Road, NUHS Tower Block, Level 11
Singapore
119228

Alerts

Be the first to know and let us send you an email when NUS Yong Loo Lin School of Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share